Reciprocal relationship from AMGN graph: Reciprocal relationship from NAUT graph: In October 2021, we entered into a research collaboration agreement with Amgen in which the Nautilus platform may be …
In February of 2025, we entered into a research collaboration with The Buck Institute for Research on Aging where the Nautilus platform may be used across a number of projects
The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs.
stems will provide. We aim to build long-term loyalty with our customers by enhancing their individual research programs, enabling their successes, and driving growth within their organizations throu…
Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: stems will provide. We aim to build long-term loyalty with our customers by enhancing their individual research progra…
oyager instrument automates the Nautilus assay chemistry concurrent with rapid optical imaging of the flow cell. The current system is an early-stage design, used for optimization of the function and…
Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from BDX grap…
Nautilus Biotechnology, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NAUT-DEBT-11170
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
NAUT-DEBT-11169
Warrants outstanding: 0
90%
xbrl warrant detail from xbrl 2021-12-31.
NAUT-DEBT
Debt stack $28.9M
90%
Market cache reports total debt of $28.9M.
Nautilus Biotechnology, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Nautilus Biotechnology, Inc..
Nautilus Biotechnology, Inc. Ownership
Holder
Name
Confidence
Evidence
NAUT-OWNER-PERCEPTIVE-ADVISORS-LLC
PERCEPTIVE ADVISORS LLC
90%
13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 84 tracked holders.
Nautilus Biotechnology, Inc. Extended Supply Chain Network